(S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma.
Oncology (Williston Park). 2016 Apr 15;30(4 Suppl 1)
Authors:
PMID: 27083676 [PubMed - as supplied by publisher]
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1WyHCfC
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου